₹ 1,807.20
-20.30 (-1.11%)
A
Aurobindo Pharma
₹ 1,807.20
Aurobindo Pharma Share Price Today
Aurobindo Pharma (AUROPHARMA) share price is trading at ₹1,807.20 on the NSE as of November 12, 2026 at 03:55 PM, down by 1.11% from its previous close of ₹1,827.50. In todays trading session AUROPHARMA reached a high of 1,821.10 and low of 1,785.40. The average traded price for today is 1,803.36. The 50 DMA stands at 1,687.81 and 200 DMA is at 1,484.50. Looking at intraday trend, the stock is in Downtrend.
Stock Overview
- Symbol : AUROPHARMA
- Open : ₹1,813.10
- Previous Close : ₹1,827.50
- Day's Range : ₹1,785.40 – ₹1,821.10
- 52-Week Range : ₹1,106.00 – ₹1,859.90
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
AUROPHARMA Stock Performance
Markets Today
High
1,821.10
Low
1,785.40
Open at
1,813.10
Prev Close
1,827.50
Volumes
22,74,622
Avg Price
1,803.36
Lower Circuit
1,626.50
Upper Circuit
1,987.90
Last Traded Details
Quantity
6
Time
15:55:18
Price Movement
Historical Performance
3 M High
1,859.90
3 M Low
1,547.70
1 Yr High
1,859.90
1 Yr Low
1,106.00
3 Yr High
1,859.90
3 Yr Low
958.50
5 Yr High
1,859.90
5 Yr Low
397.20
1-Year Performance
AUROPHARMA Pros and Cons
Consolidated Revenue grew from ₹8,286 Cr in Q2 FY26 to ₹10,263 Cr in Q2 FY27 — robust top-line expansion
Net Profit rose from ₹848 Cr in Q2 FY26 to ₹1,126 Cr in Q2 FY27 — consistent bottom-line growth
API Revenue increased from ₹961 Cr in Q2 FY26 to ₹1,162 Cr in Q2 FY27 — strong recovery in active ingredients
Domestic Loans fell from ₹1,764 Cr in Q2 FY26 to ₹604 Cr in Q2 FY27 — successful debt reduction
US Formulations Revenue jumped from ₹3,638 Cr in Q2 FY26 to ₹4,555 Cr in Q2 FY27 — key market recovery
Average FX rate climbed from 87.29 in Q2 FY26 to 95.55 in Q2 FY27 — persistent INR depreciation impacts costs
Foreign Exchange Loans rose from ₹5,720 Cr in Q2 FY26 to ₹7,628 Cr in Q2 FY27 — rising external debt exposure
Non-Beta-lactam API Revenue fluctuated from ₹292 Cr in Q2 FY26 to ₹304 Cr in Q2 FY27 — volatile segment performance
AUROPHARMA Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 27 analysts
Buy
66.67%
Hold
18.52%
Sell
14.81%
Get forecast for Price, ROA & ROE based on analyst ratings.
AUROPHARMA Share Price History
AUROPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,03,982
PE Ratio
26.30
PB Ratio
2.67
Dividend Yield
0.38%
ROE
9.25%
ROCE
13.58%
Book Value (₹)
684.77
Face Value (₹)
1.00
Analyse AUROPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 51.82% | 51.82% | 51.82% | 51.88% | 51.88% |
| Domestic Institutional Investors (DII) | 27.60% | 27.68% | 25.87% | 25.10% | 24.42% |
| Foreign Institutional Investors (FII) | 14.21% | 13.94% | 15.24% | 16.38% | 17.41% |
| Public Investors | 5.25% | 5.36% | 5.74% | 5.36% | 5.02% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Aurobindo Pharma Return Calculator
Note: Past profits do not guarantee future returns.
AUROPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
AUROPHARMA Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for AUROPHARMA
Margin on AUROPHARMA
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
AUROPHARMA Financials Summary
In Crores
AUROPHARMA Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check AUROPHARMA latest Company Filings, Investor Presentation & Conference Call details.
AUROPHARMA Revenue Growth
All values are in Crores
Revenue
Profit
Loss
AUROPHARMA Options Snapshot
AUROPHARMA Futures Snapshot
Use from 12+ Pre-built Strategies or Build Your Own to trade AUROPHARMA FnO contracts.
AUROPHARMA Similar Stocks
FAQs on AUROPHARMA
What is the share price of Aurobindo Pharma?
What is the 52W high and 52W low of Aurobindo Pharma?
What is the return on Aurobindo Pharma share?
- Past 1 year: 54.70%
- Past 3 years: 84.46%
- Past 5 years: 163.23%
What is the PE and PB Ratio of Aurobindo Pharma?
What is the EPS of Aurobindo Pharma?
What is the shareholding pattern of Aurobindo Pharma?
- DIIs - 24.42%
- FII - 17.41%
- Promoters - 51.88%
- Public Investors 5.02%
- Goverenment - 0.00%
How to buy Aurobindo Pharma shares online?
How to buy Aurobindo Pharma shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Aurobindo Pharma share
- Tap on “Buy”
Option Chain